Pliant Therapeutics, Inc.
PLRX
$1.56
$0.074.36%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -26.30M | -43.30M | -56.17M | -49.73M | -57.76M |
| Total Depreciation and Amortization | 436.00K | 447.00K | 448.00K | 458.00K | 532.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.53M | 9.17M | 11.09M | 9.79M | 10.71M |
| Change in Net Operating Assets | -2.75M | -6.92M | -4.23M | -8.18M | 14.25M |
| Cash from Operations | -21.08M | -40.60M | -48.86M | -47.66M | -32.27M |
| Capital Expenditure | 0.00 | -112.00K | -262.00K | -209.00K | -896.00K |
| Sale of Property, Plant, and Equipment | 156.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 27.77M | 35.60M | 69.38M | 39.34M | 31.86M |
| Cash from Investing | 27.92M | 35.49M | 69.11M | 39.13M | 30.96M |
| Total Debt Issued | -- | -- | -- | 1.00K | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 72.00K | 0.00 | 498.00K | 101.00K | 543.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 72.00K | 0.00 | 498.00K | 102.00K | 543.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.91M | -5.12M | 20.75M | -8.43M | -770.00K |